PharmaVOICE - 
Nov./Dec. 2020
Purchase Issue
In Every Issue
Letter from the Editor
What’s next? This is the time every year that we [...]
By

Taren Grom, Editor

Upfront
#NoGoingBack Almost three dozen signatory companies collaborated to form the [...]
By

PharmaVOICE Staff

HealthTech
Tiny Robots Tumble Through Organs to Deliver Drugs Trend Watch: [...]
By

PharmaVOICE Staff

Artificial Intelligence
Perelman School of Medicine and NIH to use AI in [...]
By

PharmaVOICE Staff

Last Word
Six Keys to Beating the Odds and Achieving Startup Success [...]
By

Sharon Cunningham, Co-founder and CEO of Shorla Pharma

On The Cover

2021 Year in Preview: The Year to Come and the Year That Was
Who knew? 2020 will be defined as one of the most tumultuous years in history: a global pandemic and civil strife giving way to innovation and greater collaboration. Even as COVID-19 vaccines make their way through safety trials and treatments receive expedited review and approval, the 2021 crystal ball remains somewhat murky in terms of [...]
By

Taren Grom, Editor

Features

SHOWCASE: Supply Chain Management: The Supply Chain: Risks and Opportunities
COVID-19 caused shockwaves throughout the global supply chain of every industry. For the pharmaceutical industry, the pandemic highlighted the fragility of the supply chain and the importance of being able to adjust to demand in a changed environment. The COVID-19 pandemic has demonstrated that companies need flexibility in their supply chain to ensure production is [...]
By

PharmaVOICE Staff

Solving Today’s Patient-Centric Supply Chains
Precision oncology, CAR-T cell therapy, gene therapy, CRISPR-Cas9 —scientific advances in the space of cell and gene therapy have made a significant impact on patient care. Biopharma company pipelines are developing advanced treatments at an inspiring pace. Even amid the ongoing COVID-19 pandemic — and sometimes in response to it — precision and personalized therapeutics [...]
By

Joe DePinto, Chief Commercial Officer, Vineti

SHOWCASE: Technology Solutions: Disrupting Innovation with Digital Solutions
Healthcare is undergoing a massive transformation with increased emphasis on digital technologies in all areas. According to Deloitte research, biopharma companies recognize that digital transformation will aid product and service innovation, greater customer engagement, and improvements across R&D, commercial, and the supply chain. Companies realize they must embrace digital solutions more proactively given growing competition [...]
By

PharmaVOICE Staff

Virtual Trials: Navigating Change and Avoiding Blinds Spots
As 2020 draws to a close, we reflect on the changes we have had to make in all facets of our lives due to the pandemic. Some were overdue and some are here to stay. Some were easy to adopt and others we resisted. Change of any sort, positive or negative, is known to be [...]
By

Kenneth G. Faulkner, Ph,D., VP, eCOA Science, ERT

Four Ways Predictive Analytics Can Strengthen Your Commercialization Efforts
Over the past few years, artificial intelligence (AI) and machine learning (ML) have been trending topics in healthcare but are now being propelled to the forefront of clinical decision support and care delivery. Some organizations, however, have been slow to adopt the utilization of predictive analytics for a number of reasons. From wasted investments in [...]
By

Steve Mack, PharmD, Chief Commercial Officer, Data & Analytics, EVERSANA

A New Framework for Improving Brand Performance
Why Managing Brand Performance is So Challenging Brand performance appears to be a straightforward concept to understand. However, the reality is that within pharmaceutical organizations, each business function has its own perspective of how brand performance should be planned for, monitored, and improved. Over the past 15 years, I have used many different definitions for [...]
By

Pankaj Gupta, Senior Principal, Commercial Services, IQVIA

Personal Technology and Artificial Intelligence Will Provide for Better Health Outcomes
More and more, pharmaceutical companies are continuing to leverage wearable technology to not only track patient information and vitals, but also track their behavior over time. When a patient’s vitals are taken at a medical facility, only a brief window of data is recorded and monitored. With wearable technology, a wider breadth of data is [...]
By

Juan Garcia, Lead Digital Developer, Ogilvy Health

Telehealth: Ready or Not — Here it Comes… It’s Here to Stay
Our world is changing more rapidly than ever before, but certain constants remain imperative in the healthcare arena — human connection and access to education. Healthcare professionals (HCPs) need to be able to connect with their patients to properly assess their conditions. HCPs need access to the latest medical studies — to newly launched drug [...]
By

Christine Molbury, Account Group Supervisor, Ogilvy Health

The Next Chapter for Real World Evidence: Validating Data with the Patient Voice
In June 2020, in accordance with the 21st Century Cures Act of 2016 and the Prescription Drug User Fee Act (PDUFA), the U.S. Food and Drug Administration (FDA) launched Project Patient Voice. This patient-focused drug development initiative facilitates systematic approaches to collecting and using meaningful patient and caregiver input, to better inform medical product development [...]
By

Ramita Tandon, Chief Operating Officer, Trio Health

COVID-19: Silver Linings
COVID-19 has stretched our industry to adjust to all types of new “normals,” yet amid all of the disruption and loss of life, there are pockets of light that are expected to lift the life sciences and its people to new heights. Of all the industries that have been impacted across the globe, the life-sciences [...]
By

Taren Grom, Editor

Expanding the Spectrum of Clinical Trials
In recent years, pharma and biotech companies have become more aware of the lack of representation of certain demographics in clinical trials and its resulting ramifications. Although the participation of women in clinical trials has improved in recent years, the participation of racial and ethnic minority groups continues to lag far behind. One of the [...]
By

Carolyn Gretton

Centering on the Patient by Decentralizing Clinical Trials
When it comes to decentralizing clinical trials, what was long a cracked door has been flung open wide by the COVID-19 pandemic. With COVID-19 sparking major upheaval in clinical trial execution, sponsors, CROs, and other supporters of drug development have been forced to adopt tools long used in decentralized clinical trials (DCTs) to safely monitor [...]
By

Carolyn Gretton

Health Consumerism on the Rise
COVID-19 has pushed the promise of healthcare consumerism into the open, creating a space where patients have a real voice in their healthcare decisions. The healthcare consumer of the future is arriving faster than anticipated, fueled by the COVID-19 pandemic. Health consumerism, which was beginning to play out slowly across the entire ecosystem, has now [...]
By

Robin Robinson

Getting Real with RWE
Real-world evidence, important for regulatory decision-making, is beginning to touch all areas of the healthcare value chain. Historically, real-world evidence (RWE) and real-world data (RWD) have been used for postmarket safety monitoring, but now sponsors are beginning to use these data sets to support clinical trial design and observational studies to generate better treatment approaches, [...]
By

Taren Grom, Editor

The New Virtual Engagement Reality
COVID-19 has created a virtual environment that is here to stay, and the industry will need to begin to adjust. From remote working to patient and physician engagement, pharma marketers and sales reps have had to rethink commercial strategies in a virtual landscape. With the onset of COVID, the shift to digital-everything isn’t going to [...]
By

Robin Robinson

Age of the Machine: The Expanded Role of AI in Pharma
AI and machine learning have the potential to transform the life-sciences industry, but barriers around implementation, process, and regulatory uncertainty must be overcome first. Artificial intelligence and machine learning are very much part of the pharmaceutical landscape today and are expected to play an even bigger role in the future. Whether in drug discovery, clinical [...]
By

Kim Ribbink

Breaking Glass: Driving Diversity, Equity, and Inclusion
As companies grapple with an emotional year in terms of the pandemic and racial inequality, efforts to address diversity and inclusion are gaining momentum. When Joe Biden and Kamala Harris won the 2020 U.S. presidential election, it signaled a huge leap forward for diversity: the first woman Vice President of the United States, the first [...]
By

Kim Ribbink

Commanders & Chiefs: Chief Experience Officers
Chief experience officers are influencing the strategic direction of their companies to address the needs and wants of their customers. Julie Adrian Customer Focus “Get closer than ever to your customers. So close that you tell them what they need well before they realize it themselves.” This quote is from Steve Jobs — a guy [...]
By

PharmaVOICE Staff

Speak Out: Making Data Central to Your CNS and Pain Trials
A Therapeutic-Area-Specific Approach to Data Capture Solutions For data capture, CNS and pain trials are demanding, with complicated eligibility criteria, extensive monitoring requirements, comprehensive data collection, and substantial demands on patients. To design a great solution, we consulted key CRO and pharma opinion leaders in eCOA, ePRO, and direct data capture (DDC). Their pain points [...]
By

Kyle Hogan, Vice President, Outcome Solutions, Clinical Ink

What Life Sciences Leaders Say During the Pandemic: 10 Key Takeaways
We are in a global pandemic that is exposing major issues in the commercial environment in which healthcare companies operate, with changes that are completely altering the landscape for the long term. Our 3rd Annual Leaders in Life Sciences Roundtable consisted of eight industry leaders with diverse perspectives and experiences discussing these changes, their impacts, [...]
By

Edward John Allera, Buchanan Ingersoll-Rooney, Timmy Garde, LevLane Advertising, Dr. Thomas Goss, Boston Healthcare Associates

FEEDBACK